Pfizer, Biontech Announce COVID-19 Vaccine Candidate Achieved Phase 3 Success

Pfizer Inc. and BioNTech SE on Monday announced that their mRNA-based vaccine candidate, BNT162b2, against SARS-CoV-2 has demonstrated evidence of efficacy against COVID-19 in participants without prior ev

read more